Safety of sublingual immunotherapy started during the pollen season

Stefania La Grutta, Jochen Sieber, Franco Frati, Giuseppe Di Cara, Stefania La Grutta, Laura Sensi, Giovanbattista Pajno, Cristoforo Incorvaia, Francesco Marcucci, Renato Ariano, Mona-Rita Yacoub

    Risultato della ricerca: Article

    12 Citazioni (Scopus)

    Abstract

    Sublingual immunotherapy (SLIT) is safer than subcutaneous immunotherapy (SCIT) and this has lead to the reconsideration of the use of ultra-rush schedules for SLIT. The aim of this study was to assess the safety of ultra-rush SLIT in pollen-allergic children according to different timing of administration in relation to the pollen season.
    Lingua originaleEnglish
    pagine (da-a)103-107
    Numero di pagine5
    RivistaCurrent Medical Research and Opinion
    Volume25
    Stato di pubblicazionePublished - 2009

      Fingerprint

    All Science Journal Classification (ASJC) codes

    • Medicine(all)

    Cita questo

    La Grutta, S., Sieber, J., Frati, F., Di Cara, G., La Grutta, S., Sensi, L., Pajno, G., Incorvaia, C., Marcucci, F., Ariano, R., & Yacoub, M-R. (2009). Safety of sublingual immunotherapy started during the pollen season. Current Medical Research and Opinion, 25, 103-107.